Consequently, high PD-L1 levels are considered to be correlated with a poor prognosis and tumor recurrence [27,28], suggesting that upregulated PD-L1 may protect surviving cancer cells from the antitumor immune response and chemotherapy-induced cell death. Here, CD274 is linked to cancer.